EODData

FRA, NGQ1: Medicure Inc

25 Sep 2026
LAST:

1.630

CHANGE:
 0.99
OPEN:
1.630
HIGH:
1.630
ASK:
0.000
VOLUME:
0
CHG(%):
152.71
PREV:
0.645
LOW:
1.630
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume

PROFILE

Name:Medicure Inc
About:Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing MC-1 for the treatment of PNPO deficiency; and TARDOXAL for neurological indications, such as Tardive Dyskinesia. It offers products through retail and mail order pharmacies. The company was founded in 1997 and is headquartered in Winnipeg, Canada.
Sector:Healthcare
Address:2-1250 Waverley Street, Winnipeg, MB, Canada, R3T 6C6
Website:https://www.medicure.com
ISIN:CA58469E4085

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:12.17 
Forward P/E:12.18 
PEG Ratio:0.16 
Price to Sales:0.70 
Price to Book:2.66 
Profit Margin:-0.23 
Operating Margin:-0.18 
Return on Assets:-0.18 
Return on Equity:-0.50 
Revenue:20.12M 
Shares:10.44M 
Market Cap:17.01M 

TECHNICAL INDICATORS

MA5:0.8983.8%
MA10:0.77112.9%
MA20:0.73124.6%
MA50:0.70134.4%
MA100:0.70134.1%
MA200:0.68138.7%
STO9:100.00 
STO14:100.00 
RSI14:74.93 
MTM14:1.00
ROC14:1.59 
ATR:0.13 
Week High:1.630.0%
Week Low:1.630.0%
Month High:1.630.0%
Month Low:1.63138.7%
Volatility:65.88 

RECENT SPLITS

Date Ratio
02 Nov 20121-15